Medical Director, Oncology Programs, AIM Specialty Health
Oncology
Dr. Michael J. Fisch, MD
|
|
Give Review
Michael Fisch is an expert in the field of Oncology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He over the years received 8 awards: "Director's Service Award", "Honorary Fellow, Division of Cancer Medicine Fellowship Program", "Fellow (FACP)", "Teacher of the Year", "Echols Scholar", "Raven Society", "Algernon Sydney Sullivan Award" and "Omicron Delta Kappa". Michael Fisch is a published doctor and has 69 publications published. The lastest was: 'Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Working after a metastatic Cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
- Retrospective Analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction.
- HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center.
- Automated pain intervention for underserved minority women with breast Cancer.
- Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With ColoRectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicente...
- Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Lab...
- Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic coloRectal cancer ...
- Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate Cancer.
- Recommended patient-reported core set of symptoms to measure in adult Cancer treatment trials.
- Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with coloRectal, breast, lung, and prostate cancer.
- Patterns and predictors of antidepressant use in ambulatory Cancer patients with common solid tumors.
- Symptom burden among young adults with breast or coloRectal cancer.
- Hepatitis C Virus Screening in Patients With Cancer Receiving Chemotherapy.
- Evaluating physician performance in oncology: moneyball becomes impactball.
- Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
- Determinants of Pain Severity Changes in Ambulatory Patients With Cancer: An Analysis From Eastern Cooperative Oncology Group Trial E2Z02.
- Clinician Perceptions of Care Difficulty, Quality of Life, and Symptom Reports for Lung Cancer Patients: An Analysis from the Symptom Outcomes and Practice Patterns (S...
- Screening for Depressed Mood in Patients With Cancer Using the MD Anderson Symptom Inventory: Investigation of a Practical Approach for the Oncologist.
- Prevalence and characteristics of moderate to severe fatigue: A multicenter study in Cancer patients and survivors.
- Recommendations for High-Priority Research on Cancer-Related Fatigue in Children and Adults.
- The validity and utility of the m. D. Anderson symptom inventory in patients with breast Cancer: evidence from the symptom outcomes and practice patterns data from the...
- The Validity and Utility of the MD Anderson Symptom Inventory in Patients With Prostate Cancer: Evidence From the Symptom Outcomes and Practice Patterns (SOAPP) Data F...
- Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors.
- The symptom burden of Cancer: Evidence for a core set of Cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and...
- A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine.
- When Patients Choose CAM over EBM-How to Negotiate Treatment.
- L-carnitine supplementation for the management of fatigue in patients with Cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-c...
- Practical guidance: the use of social media in oncology practice.
- Low rates of hepatitis B virus screening at the onset of chemotherapy.
- Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer.
- Palliative care education in Ghana: reflections on teaching in West Africa.
- Evaluation of drug interactions in patients treated with antidepressants at a tertiary care Cancer center.
- Chemoradiotherapy with or without AE-941 in stage III non-small cell lung Cancer: a randomized phase III trial.
- An international multicentre validation study of a pain classification system for Cancer patients.
- Disparities in outpatient antidepressant prescribing patterns and determinants of resource utilization at a tertiary care Cancer center.
- Molecular epidemiology, Cancer-related symptoms, and cytokines pathway.
- Integrating patient-reported outcomes into Cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
- Use of antidepressants for depression in patients with advanced Cancer.
- Chronic pain in the Cancer survivor: a new frontier.
- Fatigue trials in ambulatory Cancer patients:where do we begin and where could it possibly end?
- Antidepressant use in ambulatory Cancer patients.
- To feed or not to feed: is that the right question?
- Association between symptom distress and survival in outpatients seen in a palliative care Cancer center.
- Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.
- Use of atypical antipsychotic agents for symptom control in patients with advanced Cancer.
- Palliative care inpatient service in a comprehensive Cancer center: clinical and financial outcomes.
- Methadone versus morphine as a first-line strong opioid for Cancer pain: a randomized, double-blind study.
- Assessment of quality of life in outpatients with advanced Cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology ...
- Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
- Enterobacter endocarditis.
- The seroprevalence of cytomegalovirus among Virginia State prisoners.
- Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial.
- Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners.
- Multimorbidity: an issue of growing importance for oncologists.
- Symptom masquerade: understanding the meaning of symptoms.
- Fluoxetine versus placebo in advanced Cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
- Place of death and its predictors for local patients registered at a comprehensive Cancer center.
- E-motions: email for written emotional expression.
- Oral methadone for Cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
- Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell Cancer and survival.
- The use of an electronic patient record system to identify advanced Cancer patients and antidepressant drug use.
- Potential novel uses of thalidomide: focus on palliative care.
- Information preferences, reading ability, and emotional changes in outpatients during the process of obtaining informed consent for autologous bone-marrow transplantat...
- Treatment of depression in Cancer.
- Predicting death in patients hospitalized for community-acquired pneumonia.
- Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.
- [The rectosigmoid pouch. The Mainz pouch II. Apropos of 73 cases].
Schools
University of Virginia Main Campus
University Va
Indiana University Med Center
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- ColoRectal Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Director's Service Award
- Honorary Fellow, Division of Cancer Medicine Fellowship Program
- Fellow (FACP)
- Teacher of the Year
- Echols Scholar
- Raven Society
- Algernon Sydney Sullivan Award
- Omicron Delta Kappa
Education
-
Indiana University -
Indiana University School of Medicine -
University of Virginia -
University of Virginia School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1194811109 | |
| NPPES Provider LastName | FISCH | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194811109 |
| Last Name Of The Provider | FISCH |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Marc S. Hoffmann, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shagufta N. Naqvi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita Sabichi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Lehane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hagop M. Kantarjian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Joan M. Bull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Jonasch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marjorie Green, MD |
|
|
Dr. Milind Javle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Mohamed Haq, MB
This Doctor is OpenDoctor Recommended.
|
|
Dr. Philip A. Salem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naoto Ueno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan Zhou, MD
This Doctor is OpenDoctor Recommended.
|